IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Trails Edge Capital Partners, LP

Portfolio Profile

CIK: 0002077247 | ATLANTA, GA

Investment Profile

Style

Value

Turnover

Very High

Orientation

Concentrated trader
$629.9M
AUM
35
Positions
50.32%
Top 10 Conc.
89.78%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1LB Pharmaceuticals Inc(LBRX)1,523,022$49.4M7.85%
2Nurix Therapeutics Inc(NRIX)1,573,220$38.2M6.06%
3Immunocore Hldgs PLC(IMCR)1,063,234$33.8M5.36%
4First Tracks Biotherapeutics(TRAX)1,514,000$30.5M4.84%
54D Molecular Therapeutics in(FDMT)2,227,917$29.6M4.70%

Sector Allocation

Latest filing, equity positions only

Healthcare88.07% · $554.7M
Unclassified11.93% · $75.2M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare96.74%88.07%-8.67%
Unclassified3.26%11.93%+8.67%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$404.7M | 23 pos.
$436.5M | 27 pos.
$629.9M | 35 pos.
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

13
New
5
6
Biomarin Pharmaceutical Inc(BMRN)
512,000
$29.3M
4.65%
7Design Therapeutics Inc(DSGN)2,001,282$29.0M4.60%
8Xenon Pharmaceuticals Inc(XENE)440,000$26.6M4.22%
9Mirum Pharmaceuticals Inc(MIRM)223,312$26.1M4.15%
10Insmed Inc(INSM)230,331$24.6M3.90%
Cap SizePrev %Curr %Change
Small Cap33.67%42.87%+9.2%
Mid Cap46.32%16.11%-30.21%
Large Cap5.61%14.78%+9.17%
Micro Cap11.14%14.3%+3.16%
Unclassified3.26%11.93%+8.67%
Closed
10
Increased
7
Decreased
5
Unchanged